Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Landmark Phase News

Landmark Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Landmark Phase. Real-time updates on events, politics, business and more.

Johnson & Johnson : CARVYKTI® (ciltacabtagene autoleucel) Reduces Risk of Disease Progression or Death by 74 Percent in Earlier-Line Multiple Myeloma Treatment in the Landmark Phase 3 CARTITUDE-4 Study

June 5, 2023
News Release Media Contacts: Jessica Castles Smith +1 732-501-8181 Satu Glawe +49 172-294-6264 ... | June 5, 2023
United States Satu Glawe Binod Dhakal Division Of Hematology Clinical Development Cellular Therapy Program European Medicines Agency
Source: marketscreener.com

Investegate |BioNTech SE Announcements | BioNTech SE: Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine

December 10, 2020
BioNTech SE Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine Data from 43,448 participants, half of whom received BNT162b2 and half of whom received placebo, showed that the vaccine candidate was well tolerated and demonstrated 95% ...
United States South Africa Sylke Maas Kathrinu Jansen Chuck Triano Amy Rose
Source: investegate.co.uk

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science